uBiome
SEC Sues Founders of Bankrupt Human Microbiome Testing Firm uBiome For Fraud
The US Securities and Exchange Commission alleges that uBiome's founders misled investors in order to close a Series C financing round in 2018.
In Brief This Week: Hologic, Chembio Diagnostics, uBiome, and More
News items for the in vitro diagnostics industry for the week of Dec. 30, 2019
uBiome Files for Chapter 7 Liquidation
The company had previously declared Chapter 11 bankruptcy, which would have enabled it to reorganize to stay afloat and pay its creditors over time.
uBiome Declares Bankruptcy, Offers Assets for Sale
The San Francisco-based microbial genomics firm will sell off its product lines, testing labs, IP, and data within the next three months.
In Brief This Week: Mobidiag, Gestalt Diagnostics, Cofactor Genomics, and More
Mobidiag announced this week that it has completed a previously announced €10 million ($11.33 million) equity investment from Autobio Diagnostics.
Nov 15, 2017